Literature DB >> 3540676

Evaluation of a fluorescent method (fluorescein diacetate and ethidium bromide solution) in the study of the viability Cryptococcus neoformans strains.

B Correa, A Purchio, C R Paula, W Gambale.   

Abstract

The effectiveness of the fluorescent viability test (fluorescein diacetate-FDA and ethidium bromide-EB-solution) compared to the plaque counting test (Miles & Misra M & M) was performed on 10 samples of Cryptococcus neoformans cultivated in Sabouraud dextrose agar at 25 degrees C. The optimum incubation period of 50 minutes was determined. Growth curves of the fungal strains studied based on the mean cell number were drawn for both the FDA & EB and M & M methods. The statistical evaluation (Student's T test) of the average sum of the viable cell counts showed that the FDA-EB method is more sensitive than the M & M test for the studied species. The growth curves of the samples usually followed a homogeneous pattern comparable to other non-dimorphic fungi.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3540676     DOI: 10.1007/BF00436666

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  10 in total

1.  Vital staining of Histoplasma capsulatum with Janus Green B.

Authors:  M D Berliner; M E Reca
Journal:  Sabouraudia       Date:  1966-06

2.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

3.  A rapid, quantitative fluorescence assay for cell damage by cytotoxic antibodies.

Authors:  M Edidin
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

4.  The petite mutation in yeast. Loss of mitochondrial deoxyribonucleic acid during induction of petites with ethidium bromide.

Authors:  E S Goldring; L I Grossman; D Krupnick; D R Cryer; J Marmur
Journal:  J Mol Biol       Date:  1970-09-14       Impact factor: 5.469

5.  Complex formation between ethidium bromide and nucleic acids.

Authors:  M J Waring
Journal:  J Mol Biol       Date:  1965-08       Impact factor: 5.469

6.  Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters.

Authors:  B Rotman; B W Papermaster
Journal:  Proc Natl Acad Sci U S A       Date:  1966-01       Impact factor: 11.205

7.  The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria.

Authors:  J L Jarnagin; D W Luchsinger
Journal:  Stain Technol       Date:  1980-07

8.  Comparison of various techniques for determining viability of Paracoccidioides brasiliensis yeast-form cells.

Authors:  A Restrepo; L E Cano; C de Bedout; E Brummer; D A Stevens
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

9.  A new fluorescent viability test for fungi cells.

Authors:  V L Calich; A Purchio; C R Paula
Journal:  Mycopathologia       Date:  1979-02-28       Impact factor: 2.574

10.  Direct measurement of acetylesterase in living protist cells.

Authors:  E L Medzon; M L Brady
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

  10 in total
  5 in total

1.  Murine natural killer cells are fungicidal to Cryptococcus neoformans.

Authors:  M R Hidore; N Nabavi; F Sonleitner; J W Murphy
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  Fluorescent method for studying the morphogenesis and viability of dermatophyte cells.

Authors:  Marcia A Lopes; Olga Fischman; Walderez Gambale; Benedito Corrêa
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

3.  Morphogenesis and growth kinetics of Fusarium verticillioides.

Authors:  Carlos Alberto Granjo; Tatiana Alves dos Reis; Walderez Gambale; Benedito Corrêa
Journal:  Mycopathologia       Date:  2007-07-19       Impact factor: 2.574

4.  Rapid microscopy and use of vital dyes: potential to determine viability of Cryptococcus neoformans in the clinical laboratory.

Authors:  Brendan J McMullan; Desmarini Desmarini; Julianne T Djordjevic; Sharon C-A Chen; Michael Roper; Tania C Sorrell
Journal:  PLoS One       Date:  2015-01-27       Impact factor: 3.240

5.  Pulmonary Cryptococcosis in the Immunocompetent Patient-Many Questions, Some Answers.

Authors:  John F Fisher; Paula A Valencia-Rey; William B Davis
Journal:  Open Forum Infect Dis       Date:  2016-09-03       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.